Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells.

CAR T cell therapy uses T cells engineered with CARs to treat cancer. T cells are modified to recognize cancer cells and destroy them. The standard approach is to harvest T cells from patients, genetically alter them, then infuse the resulting CAR …

In CAR T-cell therapy, healthcare providers introduce a new gene into your T cells that changes your cells so they can do more to detect and kill cancerous cells. In some cases, CAR T-cell therapy can cure blood cancer.

Feb 26, 2025 · CAR T-cell therapy involves genetically engineering a patient's own T cells (red) to attack cancer cells (red and blue). Just a decade or so ago, immunotherapy was considered an exciting new way to treat some people with very advanced forms of a few types of cancer. Today, it’s a cornerstone of cancer treatment.

Mar 19, 2025 · Chimeric antigen receptor T-cell therapy, or CAR-T cell therapy, is one type of immunotherapy. Sometimes likened to a “smart drug” or “living drug,” CAR-T cell therapy relies on genetically modified immune cells to recognize and destroy cancer cells.

Jun 15, 2024 · CAR-T cell therapy is an individualized cell-based technique that involves removing some of your own white blood cells, including T cells. To make CAR-T cells, the collected T cells are genetically treated in the lab to produce special receptors called chimeric antigen receptors, or CARs.

Scientists are trying to find ways to get T cells to recognise cancer cells. One possible way to do this is CAR T-cell therapy. How does CAR T-cell work? T cells are collected from the blood. This process is called apheresis. In the laboratory, scientists change the T cells to become CAR T …

Jan 12, 2023 · CAR T-cell therapy removes T-cells from the blood and changes them in the lab by inserting genetic information that tells them to make the receptors for specific types of cancer cells. The re-engineered T-cells are then put back in the patient's body so they can identify and kill the cancer cells.

Aug 31, 2023 · Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) is a form of immunotherapy in which healthcare professionals remove a person’s T cells — white blood cells known as lymphocytes that are involved in the immune system response — and genetically modify them to produce chimeric antigen receptors (CARs).

Jan 20, 2023 · CAR T cell therapy is a type of immunotherapy used to treat lymphoma, multiple myeloma and some forms of leukemia. The treatment modifies T cells so that they can better recognize and attack cancer. To learn what to expect if you need CAR T cell therapy, we spoke with lymphoma and myeloma specialist Sairah Ahmed, M.D.